Home›Companies›Healthcare›Innovein

Innovein, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 6, 2023·Suggest an edit

About Innovein

Innovein is a private company based in Santa Rosa, California. It has reported $13,294,097 raised in two offerings on Form D since July 2018. Its chief executive is David Hovda.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 25, 2023Feb 6, 2023$2,545,164of $11.9M target7$363KEquityRule 506(b)Form D ↗
Jun 15, 2018Jul 3, 2018amended Oct 10, 2018$10,748,933of $11.0M target66$162KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$13,294,097

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Innovein's Form D filed Feb 6, 2023.

AW
RW
DH
David Hovda
Chief Executive Officer and director
AC
Albert Chin
Director
Also an executive officer and director at TAS Medical.

Earlier filings also listed Thomas Kramer (executive officer, last listed Oct 2018).

Sources

  1. SECInnovein, Inc. Form D, filed Jul 3, 2018
  2. SECInnovein, Inc. filing history